Form 4: Accelerate Diagnostics Director Exercises Stock Options and Reports Beneficial Ownership

Director Hany Massarany reports exercising stock options and changes in beneficial ownership of Accelerate Diagnostics, Inc. shares.

Summary

• On June 28, 2024, Hany Massarany, a director of Accelerate Diagnostics, Inc., exercised restricted stock units (RSUs) converting them into 4,737 shares of common stock.
• The exercise price for these RSUs was $0.
• Following the transaction, Massarany directly owns 36,891 shares of Accelerate Diagnostics common stock.
• Massarany also indirectly owns 3,000 shares through the Massarany Family Trust dated November 15, 2012.
• The RSUs were granted on June 28, 2023, and vest in five equal annual installments beginning on June 28, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting a transaction. The exercise of options could be seen as a slightly positive sign, but it's not a major event.

Positives

• The exercise of RSUs by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.

Key Dates